Denise A Cloutier

599 total citations
7 papers, 488 citations indexed

About

Denise A Cloutier is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Denise A Cloutier has authored 7 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Denise A Cloutier's work include Lysosomal Storage Disorders Research (6 papers), Glycogen Storage Diseases and Myoclonus (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Denise A Cloutier is often cited by papers focused on Lysosomal Storage Disorders Research (6 papers), Glycogen Storage Diseases and Myoclonus (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). Denise A Cloutier collaborates with scholars based in United States. Denise A Cloutier's co-authors include Barry J. Byrne, Cathryn Mah, David D. Fuller, Darin J. Falk, Melissa A. Lewis, Thomas J. Fraites, Irene Zolotukhin, Kerry O. Cresawn, Lara R. DeRuisseau and Sean Germain and has published in prestigious journals such as Development, Human Molecular Genetics and Molecular Therapy.

In The Last Decade

Denise A Cloutier

7 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise A Cloutier United States 7 299 212 184 127 101 7 488
Kerry O. Cresawn United States 8 208 0.7× 241 1.1× 136 0.7× 65 0.5× 67 0.7× 9 438
Anne Chun-Hui Tsai United States 10 407 1.4× 153 0.7× 99 0.5× 284 2.2× 102 1.0× 11 579
Peter Heim Germany 6 207 0.7× 141 0.7× 75 0.4× 56 0.4× 56 0.6× 7 335
Denise Griffiths United States 7 157 0.5× 146 0.7× 73 0.4× 26 0.2× 48 0.5× 8 341
Sandra Motas Spain 6 215 0.7× 150 0.7× 146 0.8× 19 0.1× 94 0.9× 6 359
Heather Cahan United States 7 265 0.9× 119 0.6× 76 0.4× 71 0.6× 64 0.6× 16 418
Johan Deniaud France 6 103 0.3× 164 0.8× 137 0.7× 24 0.2× 51 0.5× 9 280
Luca Maggioni Spain 5 168 0.6× 141 0.7× 156 0.8× 15 0.1× 77 0.8× 7 321
Kirsten E. Coleman United States 10 84 0.3× 211 1.0× 184 1.0× 38 0.3× 37 0.4× 14 333
Céline Cluzeau United States 12 250 0.8× 274 1.3× 57 0.3× 36 0.3× 57 0.6× 15 529

Countries citing papers authored by Denise A Cloutier

Since Specialization
Citations

This map shows the geographic impact of Denise A Cloutier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise A Cloutier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise A Cloutier more than expected).

Fields of papers citing papers by Denise A Cloutier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise A Cloutier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise A Cloutier. The network helps show where Denise A Cloutier may publish in the future.

Co-authorship network of co-authors of Denise A Cloutier

This figure shows the co-authorship network connecting the top 25 collaborators of Denise A Cloutier. A scholar is included among the top collaborators of Denise A Cloutier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise A Cloutier. Denise A Cloutier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Falk, Darin J., Meghan S. Soustek, Adrian G. Todd, et al.. (2015). Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice. Molecular Therapy — Methods & Clinical Development. 2. 15007–15007. 47 indexed citations
2.
Falk, Darin J., Cathryn Mah, Meghan S. Soustek, et al.. (2013). Intrapleural Administration of AAV9 Improves Neural and Cardiorespiratory Function in Pompe Disease. Molecular Therapy. 21(9). 1661–1667. 65 indexed citations
3.
Byrne, Barry J., Darin J. Falk, Christina A. Pacak, et al.. (2011). Pompe disease gene therapy. Human Molecular Genetics. 20(R1). R61–R68. 72 indexed citations
4.
Mah, Cathryn, Darin J. Falk, Sean Germain, et al.. (2010). Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established Disease. Molecular Therapy. 18(3). 502–510. 67 indexed citations
5.
Mah, Cathryn, Christina A. Pacak, Kerry O. Cresawn, et al.. (2007). Physiological Correction of Pompe Disease by Systemic Delivery of Adeno-associated Virus Serotype 1 Vectors. Molecular Therapy. 15(3). 501–507. 79 indexed citations
6.
Rucker, Mary Jo, Thomas J. Fraites, Stacy Porvasnik, et al.. (2004). Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease. Development. 131(12). 3007–3019. 52 indexed citations
7.
Fraites, Thomas J., R. Andrew Shanely, Denise A Cloutier, et al.. (2002). Correction of the Enzymatic and Functional Deficits in a Model of Pompe Disease Using Adeno-associated Virus Vectors. Molecular Therapy. 5(5). 571–578. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026